Ravindra Uppaluri, MD, PhD

home / authors / ravindra-uppaluri-md-phd

Ravindra Uppaluri, MD, PhD, is the chair of otolaryngology at Brigham and Women's Hospital, director of head and neck surgical oncology at Dana-Farber Brigham Cancer Center, and an associate professor of otolaryngology/head and neck surgery at Harvard Medical School.

Articles

April 27th 2025

KEYNOTE-689 Findings May Reshape Resectable Head and Neck Cancer Care: Ravindra Uppaluri, MD, PhD

Brooke McCormick Ravindra Uppaluri, MD, PhD

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the need for a multidisciplinary approach to translate the study's findings into real-world care for patients with resectable head and neck cancer.

April 27th 2025

Pembrolizumab Before, After Surgery Improves Head and Neck Cancer Outcomes: Ravindra Uppaluri, MD, PhD

Brooke McCormick Ravindra Uppaluri, MD, PhD

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck cancer treatment.